drugset
Drugs / GVAX® Prostate Cancer Vaccine
last change Apr 2005 re-read 3 minutes ago

GVAX® Prostate Cancer Vaccine

also known as GVAX

Vaccine

Developed for
prostate cancer
Investigated by
Cell Genesys

Trials 1

today NCT00140348 · Ph 1/2
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00140348 Dec 2001 → Apr 2005 prostate cancer Cell Genesys Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GVAX Prostate Cancer Vaccine “Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine” NCT00140348 ↗
Known as GVAX “Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine” NCT00140348 ↗
Modality Vaccine “GVAX® Prostate Cancer Vaccine” NCT00140348 ↗